Becton, Dickinson and Co. (BDX)
Health Care – SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Headquarters
- United States
- Employees
- 72,000
- Market Cap
- $46.4B
About Becton, Dickinson and Co.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
SentiSense also tracks daily options readings for Becton, Dickinson and Co.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Becton, Dickinson and Co. stock analysis, sentiment tracking, and market intelligence on SentiSense.